Diploma (LON:DPLM) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?

Key Points

• Diploma PLC's stock price has surpassed its 200-day moving average, reaching a high of GBX 5,450 ($73.68) during trading.
• Research firms have varying ratings for the stock, with a recent upgrade from Berenberg Bank to a "buy" rating and a price target increase to GBX 5,750.
• The company reported a net margin of 9.25% and an expected EPS of approximately 163.80 for the current fiscal year, reflecting solid performance metrics.

Diploma PLC (LON:DPLM - Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 4,538.29 ($61.26) and traded as high as GBX 5,450 ($73.57). Diploma shares last traded at GBX 5,430 ($73.30), with a volume of 132,062 shares trading hands.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. JPMorgan Chase & Co. restated a "neutral" rating and issued a GBX 4,440 price objective on shares of Diploma in a report on Wednesday, August 6th. Berenberg Bank lifted their price objective on shares of Diploma from GBX 5,600 to GBX 5,750 and gave the company a "buy" rating in a report on Friday, July 18th. Finally, Shore Capital restated a "hold" rating and issued a GBX 5,100 price objective on shares of Diploma in a report on Thursday, July 17th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Diploma presently has an average rating of "Moderate Buy" and a consensus target price of GBX 5,097.50.

Diploma Stock Up 0.1%

The business's fifty day moving average price is GBX 5,147.77 and its 200 day moving average price is GBX 4,558.02. The firm has a market capitalization of £7.23 billion, a price-to-earnings ratio of 62.34, a PEG ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.